PierianDx

PierianDx

PierianDx

PierianDx enables clinical labs to seamlessly manage and interpret complex genetic tests for individualized diagnosis and ultimately better treatment.
Raised
$9.3M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
$9,250,000
Venture capital (Series A) - 2016
Health Catalyst Capital Management Inova Translational Medicine Institute ARUP Laboratories +1
Team Size
1–10
Employees
FinSMEs

PierianDx Closes $27M Series B Financing

$9,250,000 Venture capital (Series A)
vcaonline , FinSMEs

Venture Capital Access Online | Venture Capital News

Health Funding